Technology News and Research

RSS

KFHP/H reports net income of $2.1 billion for 2009

Kaiser Foundation Health Plan, Inc., Kaiser Foundation Hospitals and their subsidiaries (KFHP/H) reported today a combined total operating revenue of $10.6 billion for the quarter ended Dec. 31, 2009, compared to $10.0 billion in the same period in 2008. Operating income was $214 million, equal to two percent of revenue, in the fourth quarter of 2009, compared to $108 million in the same quarter of the prior year. Net non-operating income was $276 million in the fourth quarter of 2009, compared to a net non-operating loss of $1.1 billion in the same quarter of 2008.

15 Feb 2010

Bacterin International completes $3M private placement of Secured Convertible Promissory Notes

Bacterin International, Inc. (Bacterin), a developer of biological scaffolds for orthopedic indications, today announced the completion of a $3 million private placement of Secured Convertible Promissory Notes led by Middlebury Securities, LLC.

14 Feb 2010

Bluewater Health licenses Medworxx LMS and PDMS

Medworxx Inc., provider of healthcare solutions for patient flow, compliance and education, announced that Bluewater Health has licensed the Medworxx Learning Management System and Policy and Document Management System. With the addition of Bluewater Health, every hospital within the Erie St. Clair Local Health Integration Network (ESC LHIN) is a Medworxx customer.

12 Feb 2010

Adult stem cell transplant therapy may help prevent amputations from PAD

Grant Medical Center recently completed the nation's first published study of a new procedure that may give hope to millions of patients facing lower limb amputations from peripheral arterial disease (PAD). PAD is a painful circulatory problem in the legs that affects 10 million Americans. If left untreated, it can lead to serious complications such as stroke, amputation and death.

12 Feb 2010

TechniScan 3D whole breast imaging system to be presented at SPIE conference

TechniScan, Inc.'s cofounder and scientist-mathematician, James Wiskin, Ph.D, will be a presenting speaker at the SPIE Medical Imaging Conference in San Diego this weekend.

12 Feb 2010

VR technology plays important role in treating patients with PTSD

Posttraumatic stress disorder (PTSD) threatens to overload healthcare and social support systems worldwide as the number of cases rises and existing treatments are not sufficiently effective.

12 Feb 2010

Viral Genetics: Company update

Our mission is to bring new drug compounds to the marketplace. And we've never been in a stronger position to deliver on that promise. We've built the solid foundation needed to take drug therapies from the laboratory to the marketplace. After years in development, we believe several of our most promising compounds are moving closer to clinical trials.

12 Feb 2010

Histone modifications associated with pancreatic cancer development and progression

Specific chemical modifications to proteins called histones, which are found in the nucleus of cells and act as spools around which DNA is wound, can be used to predict prognosis and response to treatment in subsets patients with pancreatic cancer, a study by researchers at UCLA's Jonsson Comprehensive Cancer Center has found.

12 Feb 2010

Gold nanoparticles for cancer treatment

World Gold Council (WGC) has today published 'Gold for Good: Gold and nanotechnology in the age of innovation', a research paper detailing new scientific and technological innovations using gold. The report, which was produced in conjunction with Cientifica Ltd, the world's leading source of global business and investor intelligence about nanotechnologies, demonstrates how gold nanoparticles offer the potential to overcome many of the serious issues facing mankind over the coming decades.

12 Feb 2010

World leaders need to alter their notions on sustainable agriculture to prevent starvation catastrophe

Yields from some of the most important crops begin to decline sharply when average temperatures exceed about 30 degrees Celsius, or 86 Fahrenheit. Projections are that by the end of this century much of the tropics and subtropics will regularly see growing season temperatures above that level, hotter than the hottest summers now on record.

12 Feb 2010

Healthcare thought leaders and experts to meet in MCEG 2010 Annual Forum

The Managed Care Executive Group has gathered some of healthcare's most distinguished thought leaders and experts on healthcare reform to meet March 21-24 in Fort Lauderdale Florida for their Annual Forum entitled "Reform + Evolution = Revolution".

12 Feb 2010

Glycotex announces the expansion of patent portfolio in Advanced Wound Healing for GLYC-101

Glycotex, Inc. today announced the expansion of its patent portfolio in Advanced Wound Healing for its product candidate GLYC-101 currently in clinical phase 2 in the United States.

12 Feb 2010

Smart Holograms launches new Verif-EYE bio-optical, interactive visual sensor

Today, Smart Holograms, a UK-Based Technology Company, announced the commercial availability of its new Verif-EYE™ bio-optical, interactive visual sensor that allows consumers to ‘self validate’ their purchases prior to consumption or use to ensure the product is genuine and tamper-free.

12 Feb 2010

Encouraging results from Circassia's ToleroMune ragweed allergy T-cell vaccine phase II clinical trial

Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that its ToleroMune(R) ragweed allergy T-cell vaccine achieved positive results in a recently completed phase II clinical trial. Ragweed allergy is particularly common in America, where it affects approximately 25% of the population. Circassia's latest clinical results follow two earlier successful phase II studies with the company's T-cell vaccine against cat allergy.

12 Feb 2010

MITA endorses eight key principles to reduce unnecessary radiation exposure and medical errors

The Medical Imaging & Technology Alliance (MITA), the leading association representing the manufacturers, innovators and developers of medical imaging and radiation therapy systems, today endorsed eight key principles to reduce exposure to unnecessary medical radiation, further minimize medical errors and improve reporting of adverse events.

12 Feb 2010

Formatech issued patent covering novel formulation methods to enhance solubility of certain hydrophobic compounds

Today, Formatech, Inc. announced the issuance of U.S. patent 7,659,310, entitled “Methods of Enhancing Solubility of Agents” which covers novel formulation methods to enhance the solubility of certain hydrophobic compounds.

12 Feb 2010

American Red Cross raises $32M in mobile giving for ongoing relief efforts in Haiti

Hundreds of thousands of cell phone users have made $10 donations to the American Red Cross Haiti Relief and Development Fund by sending the word "Haiti" to 90999, raising a record-shattering $32 million in mobile giving for the ongoing relief efforts.

12 Feb 2010

MCEG and HTMS report examines potential impact of reform on regional health plans

The Managed Care Executive Group and HTMS, with the help of Health Dialog, have jointly released a new report which examines strategic and operational priorities for 2010, as well as the potential impact of reform on regional health plans which composes the majority of the MCEG membership.

12 Feb 2010

IBM, VLSCI scientists to use Blue Gene supercomputer to study human disease

IBM today announced a Research collaboratory in Melbourne, Australia, where scientists from the Victorian Life Sciences Computational Initiative at the University of Melbourne and the IBM Research Computational Biology Center will use high performance computing – including IBM's Blue Gene supercomputer – to study human disease.

12 Feb 2010

Sustamine L-Alanyl-L-Glutamine supplement increases performance in endurance exercise and activity

A clinical study by Dr. Jay Hoffman, PhD, professor and chair of the Department of Health and Exercise Science at the College of New Jersey, has shown Sustamine™ L-Alanyl-L-Glutamine, increases performance in endurance exercise and activity. The study was published on February 3, 2010, in the Journal of the International Society of Sports Nutrition (JISSN), a peer-reviewed journal covering various aspects of sports nutrition, supplementation, exercise metabolism, and/or scientific policies related to sports nutrition.

12 Feb 2010

Technology News and Research

KFHP/H reports net income of $2.1 billion for 2009

Bacterin International completes $3M private placement of Secured Convertible Promissory Notes

Bluewater Health licenses Medworxx LMS and PDMS

Adult stem cell transplant therapy may help prevent amputations from PAD

TechniScan 3D whole breast imaging system to be presented at SPIE conference

VR technology plays important role in treating patients with PTSD

Viral Genetics: Company update

Histone modifications associated with pancreatic cancer development and progression

Gold nanoparticles for cancer treatment

World leaders need to alter their notions on sustainable agriculture to prevent starvation catastrophe

Healthcare thought leaders and experts to meet in MCEG 2010 Annual Forum

Glycotex announces the expansion of patent portfolio in Advanced Wound Healing for GLYC-101

Smart Holograms launches new Verif-EYE bio-optical, interactive visual sensor

Encouraging results from Circassia's ToleroMune ragweed allergy T-cell vaccine phase II clinical trial

MITA endorses eight key principles to reduce unnecessary radiation exposure and medical errors

Formatech issued patent covering novel formulation methods to enhance solubility of certain hydrophobic compounds

American Red Cross raises $32M in mobile giving for ongoing relief efforts in Haiti

MCEG and HTMS report examines potential impact of reform on regional health plans

IBM, VLSCI scientists to use Blue Gene supercomputer to study human disease

Sustamine L-Alanyl-L-Glutamine supplement increases performance in endurance exercise and activity

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News